Coventry Health Care (NYSE: CVH) had its price target raised by Deutsche Bank from $44.00 to $46.00 in a research report sent to investors on Friday morning.

Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group reiterated a hold rating on shares of Coventry Health Care in a research note to investors on Wednesday, March 6th. They now have a $46.00 price target on the stock. Separately, analysts at Jefferies & Co. raised their price target on shares of Coventry Health Care from $42.00 to $46.00 in a research note to investors on Tuesday, February 12th. Finally, analysts at Jefferies & Co. raised their price target on shares of Coventry Health Care from $42.00 to $46.00 in a research note to investors on Tuesday, February 12th.

One investment analyst has rated the stock with a buy rating, and thirteen have issued a hold rating to the company’s stock. The company currently has an average rating of hold and a consensus price target of $44.67.

Shares of Coventry Health Care traded up 0.43% during mid-day trading on Friday, hitting $46.76. Coventry Health Care has a one year low of $27.72 and a one year high of $46.92. The stock’s 50-day moving average is currently $46.05. The company has a market cap of $6.294 billion and a P/E ratio of 13.23.

Coventry Health Care, Inc. (Coventry) is a diversified national managed healthcare company based in Bethesda, Maryland.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.